Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript August 14, 2025
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.55.
Operator: Welcome to the conference call hosted by Daré Bioscience Therapeutics Company’s Second Quarter 2025 Financial Results and to provide a business update. This call is being recorded. My name is [ Jericho, ] and I will be your operator today. With us today from Daré are Sabrina Martucci Johnson,...
